Sutro Biopharma, Inc. STRO
$28.85
▲ +8.76% 24H
About
Sutro Biopharma, Inc. is a clinical-stage biotechnology company specializing in oncology, headquartered in South San Francisco, California. The company focuses on discovering, developing, and manufacturing next-generation antibody-drug conjugates (ADCs) using its proprietary, integrated cell-free protein synthesis plat…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees133
TickerSTRO
Statistics
Market Cap$478.0M
Revenue (TTM)$102.5M
Net Income-$191.1M
Net Margin-186.5%
EPS$-22.49
P/E-1.29
P/S4.79
P/B-5.65
EV/EBITDA-3.11
ROE144.3%
Dividend Yield—
Price$28.85
Data: Twelve Data · Revenue = mcap / P/S